Innovative Therapies Transform Hemophilia A Care
Hemophilia A, a genetic disorder caused by a deficiency in clotting factor VIII, traditionally required frequent infusions, posing accessibility and cost challenges. Emerging treatments like gene therapy, extended half-life products, and engineered stem cells are revolutionizing care by reducing bleeding events and improving quality of life. Discover the transformative horizon these innovations present. Exploring New […]
3 minute read